Scaling the next generation of T cell therapies

Advancing next-generation T cell therapies requires bridging innovative targeting strategies with scalable, robust manufacturing approaches.

Explore how these innovations are translated into scalable, manufacturable, and digitally enabled T cell therapies.

Why watch?

Understand how emerging targeting strategies expand the therapeutic potential beyond traditional CAR T
Learn how these innovations are translated into scalable, digitally enabled, and controlled manufacturing processes
Gain practical perspectives bridging academic discovery and industrial implementation